The molecule has a completely new dual mode of action (MOA) that simultaneously targets two key pathways in weeds, dihydropteridine reductase and shikimate kinase diphosphate synthase, making it harder for weeds to survive and less likely to develop resistance. Rimisoxafen will help control herbicide-resistant broadleaf weeds, particularly the challenging amaranth species in key row crops such as corn and soybeans.
Currently, the molecule is being submitted for regulatory approval. FMC anticipates launching a product containing rimisoxafen before 2030, marking a significant milestone in the advancement of FMC's innovation pipeline.